Table 3.
Comparison of ΔMAS,ΔFMA and ΔMBI scores between the two groups (duration of the disease 4–6 months)
| Outcomes | CR | TN | Between 2 Groups | |
|---|---|---|---|---|
| z | P‐value | |||
| ΔMAS‐Elbow flexors muscle | ||||
| Baseline‐WK2 | 0.13 ± 0.34 (0.03, 0.23) | 0.23 ± 0.43 (0.10, 0.36) | 1.67 | 0.1960 |
| Baseline‐WK4 | 0.28 ± 0.54 (0.12, 0.44) | 0.55 ± 0.59 (0.36, 0.73) | 4.70 | 0.0301 |
| Baseline‐MTH3 | 0.29 ± 0.55 (0.11, 0.46) | 0.68 ± 0.77 (0.43, 0.94) | 7.24 | 0.0071 |
| Baseline‐MTH6 | 0.38 ± 0.59 (0.18, 0.58) | 0.88 ± 0.84 (0.59, 1.18) | 8.93 | 0.0028 |
| ΔMAS‐Wrist flexors muscle | ||||
| Baseline‐WK2 | 0.06 ± 0.25 (−0.01, 0.14) | 0.07 ± 0.26 (−0.01, 0.15) | 0.01 | 0.9107 |
| Baseline‐WK4 | 0.26 ± 0.61 (0.08, 0.44) | 0.33 ± 0.61 (0.14, 0.52) | 0.35 | 0.5537 |
| Baseline‐MTH3 | 0.31 ± 0.60 (0.12, 0.50) | 0.53 ± 0.80 (0.26, 0.79) | 1.20 | 0.2724 |
| Baseline‐MTH6 | 0.30 ± 0.78 (0.04, 0.56) | 0.56 ± 0.86 (0.26, 0.86) | 1.43 | 0.2325 |
| ΔMAS‐Finger flexors muscle | ||||
| Baseline‐WK2 | 0.09 ± 0.41 (−0.03, 0.20) | 0.14 ± 0.35 (0.03, 0.25) | 1.00 | 0.3161 |
| Baseline‐WK4 | 0.33 ± 0.60 (0.15, 0.50) | 0.29 ± 0.51 (0.13, 0.44) | 0.01 | 0.9231 |
| Baseline‐MTH3 | 0.29 ± 0.74 (0.05, 0.52) | 0.37 ± 0.54 (0.19, 0.55) | 0.50 | 0.4789 |
| Baseline‐MTH6 | 0.24 ± 0.88 (−0.02, 0.51) | 0.44 ± 0.66 (0.21, 0.67) | 0.92 | 0.3371 |
| ΔFMA‐T | ||||
| Baseline‐WK2 | −1.96 ± 4.19 (−3.19, −0.73) | −1.93 ± 3.92 (−3.14, −0.72) | 0.00 | 0.9748 |
| Baseline‐WK4 | −7.20 ± 7.09 (−9.30, −5.09) | −5.76 ± 7.57 (−8.12, −3.40) | 0.84 | 0.3617 |
| Baseline‐MTH3 | −12.74 ± 10.77 (−16.10, −9.38) | −13.00 ± 10.88 (−16.58, −9.42) | 0.01 | 0.9142 |
| Baseline‐MTH6 | −15.32 ± 14.80 (−20.26, −10.39) | −16.15 ± 14.49 (−21.20, −11.09) | 0.06 | 0.8138 |
| ΔFMA‐U | ||||
| Baseline‐WK2 | −1.43 ± 2.44 (−2.14, −0.71) | −1.12 ± 2.71 (−1.95, −0.28) | 0.32 | 0.5702 |
| Baseline‐WK4 | −4.48 ± 4.59 (−5.84, −3.12) | −3.71 ± 5.72 (−5.50, −1.93) | 0.48 | 0.4896 |
| Baseline‐MTH3 | −7.98 ± 6.84 (−10.11, −5.85) | −8.50 ± 8.58 (−11.32, −5.68) | 0.09 | 0.7625 |
| Baseline‐MTH6 | −9.76 ± 9.46 (−12.91, −6.60) | −10.85 ± 10.93 (−14.67, −7.04) | 0.20 | 0.6522 |
| ΔMBI | ||||
| Baseline‐WK2 | −2.34 ± 5.23 (−3.87, −0.81) | −2.14 ± 3.69 (−3.27, −1.00) | 0.04 | 0.8350 |
| Baseline‐WK4 | −6.37 ± 7.04 (−8.46, −4.28) | −6.17 ± 6.07 (−8.06, −4.28) | 0.02 | 0.8857 |
| Baseline‐MTH3 | −12.26 ± 10.64 (−15.58, −8.95) | −12.63 ± 10.17 (−15.98, −9.29) | 0.03 | 0.8745 |
| Baseline‐MTH6 | −14.73 ± 14.45 (−19.55, −9.91) | −16.32 ± 11.92 (−20.48, −12.17) | 0.25 | 0.6155 |
The data are presented as the mean ± standard deviation (SD), 95%CI. ΔChange in value before versus after treatment.
MAS, Modified Ashworth Scale; FMA‐U, Fugl‐Meyer upper limb score; FMA‐T, Fugl‐Meyer total score; MBI, Modified Barthel Index; WK, week; MTH, month. CR, Conventional rehabilitation group TN, Tui Na group.